Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02515890 · ClinicalTrials.gov registry record · Phase 1
Memory Modulation by Pain During Anesthesia
A Phase 1 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT02515890 is a Phase 1 study that has completed, run by University of Pittsburgh. The registered enrollment target is 32 participants.
The verdict
NCT02515890, a Phase 1 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of pain on facilitating long-term auditory memory in the presence and absence of distinct intravenous anesthetics. The ability to identify previously presented words from a list assessed the degree of memory formation. In a subset of subjects, functional magnetic resonance imaging was used to identify the neural correlates of memory inhibition or facilitation by the combination of pain and anesthetic used.
Interventions
- DRUG Ketamine
- DRUG Midazolam
- DRUG Dexmedetomidine
- DEVICE Peripheral nerve stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2015-11-19 |
| Est. Completion | 2018-12-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02515890
The ClinicalTrials.gov registry entry for NCT02515890 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Ketamine is the first listed.
NCT02515890 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02515890 about?
NCT02515890 is a clinical study titled "Memory Modulation by Pain During Anesthesia". The purpose of this study is to determine the effects of pain on facilitating long-term auditory memory in the presence and absence of distinct intravenous anesthetics. The ability to identify previously presented words from a list assessed the degree of memory formation. In a subset of subjects, fu...
What is the current status of trial NCT02515890?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2015-11-19. Estimated completion is 2018-12-12.
What interventions are being tested in trial NCT02515890?
The interventions under investigation include: Ketamine (DRUG), Midazolam (DRUG), Dexmedetomidine (DRUG), Peripheral nerve stimulation (DEVICE).
Who is sponsoring clinical trial NCT02515890?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.